As a leading publisher for regulatory professionals, RAPS is always interested in new manuscripts. Whether your idea involves prescription drugs, generics, over-the-counter products, biologics, medical devices, IVDs, good pharmaceutical practices or any other regulated-product topic, RAPS wants to hear from you.

Books

About RAPS Publications

RAPS is the world's leading publisher for professionals dealing with regulated healthcare products, offering resources for every level of regulatory professional across all healthcare product lines and lifecycles. All our publications are written by regulatory professionals, for regulatory professionals.

Our customers expect the most up-to-date, accurate, and insightful information available, and we make every effort to ensure our publications are of the highest quality. Every publication is reviewed by experts in the field, to ensure all content is accurate and relevant. The Editorial Advisory Committee (EAC) oversees all submissions with an established editorial process. In addition, RAPS staff work collaboratively with authors throughout the publication process.

Writing Opportunities

We are actively pursuing book proposals related to:

  • Data Protection and Cybersecurity
  • Global Postmarketing Requirements: Drugs
  • Global Postmarketing Requirements: Devices
  • Expedited Pathways
  • Clinical Trials
  • Codeveloping Drugs and Companion Diagnostics

Submission

To submit your proposal or if you have any questions about the above and would like to discuss your proposal prior to submission, you can email our publications team directly at books@raps.org.

View the book author style guide.

Feature Articles

In addition, RAPS Regulatory Focus, our flagship online publication, gives RAPS members continuous access to new feature articles weekly and to the RF Quarterly themed series. For 2023, we are looking for articles on the following topics:

  • January: Advanced therapy medicinal products, incl. combination products
  • February: eCTD submissions
  • RFQ 1 (March): Patient-centric regulatory practice
  • April: Professional development and career advancement
  • May: Update on EU IVDR and MDR
  • RFQ 2 (June): Global health authorities
  • July: Regulatory intelligence
  • August: CMC regulatory issues
  • RFQ 3 (September): Leadership (print issue distributed at RAPS Convergence 2023)
  • October: The EU Clinical Trials Regulation
  • November: Regulatory Science
  • RFQ 4 (December): 2023 RAPS Convergence

Submission

If you are interested in writing on any of the above topics, have a proposal for a topic, or have questions and would like to discuss the editorial process prior to submission, please contact Renée Matthews at rmatthews@raps.org.

View the feature article author style guide.

Benefits of Publishing with RAPS

  • Showcase your regulatory knowledge and experience
  • Receive review feedback from industry experts
  • Earn RAC recertification points for each book published during a recertification period (three years)
    • 5 points for chapter authors, co-authors and article authors
    • Up to 15 points for book authors or co-authors
  • Reach RAPS’ target audience of 55,000+
  • Enjoy cross-promotional opportunities with RAPS educational programs, newsletters, webinars, and RAPS Regulatory Focus
  • Book authors and co-authors receive bi-annual royalties